Bakos E - Search Results

1

Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters.

Tusnády GE, Bakos E, Váradi A, Sarkadi B. Tusnády GE, et al. Among authors: bakos e. FEBS Lett. 1997 Jan 27;402(1):1-3. doi: 10.1016/s0014-5793(96)01478-0. FEBS Lett. 1997. PMID: 9013845 Free article. Review.

2

Structure and tissue-specific expression of the Drosophila melanogaster organellar-type Ca(2+)-ATPase gene.

Magyar A, Bakos E, Váradi A. Magyar A, et al. Among authors: bakos e. Biochem J. 1995 Sep 15;310 ( Pt 3)(Pt 3):757-63. doi: 10.1042/bj3100757. Biochem J. 1995. PMID: 7575407 Free PMC article.

3

Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein.

Müller M, Bakos E, Welker E, Váradi A, Germann UA, Gottesman MM, Morse BS, Roninson IB, Sarkadi B. Müller M, et al. Among authors: bakos e. J Biol Chem. 1996 Jan 26;271(4):1877-83. doi: 10.1074/jbc.271.4.1877. J Biol Chem. 1996. PMID: 8567633 Free article.

4

Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region.

Bakos E, Klein I, Welker E, Szabó K, Müller M, Sarkadi B, Váradi A. Bakos E, et al. Biochem J. 1997 May 1;323 ( Pt 3)(Pt 3):777-83. doi: 10.1042/bj3230777. Biochem J. 1997. PMID: 9169612 Free PMC article.

5

Phosphorylation site mutations in the human multidrug transporter modulate its drug-stimulated ATPase activity.

Szabó K, Bakos E, Welker E, Müller M, Goodfellow HR, Higgins CF, Váradi A, Sarkadi B. Szabó K, et al. Among authors: bakos e. J Biol Chem. 1997 Sep 12;272(37):23165-71. doi: 10.1074/jbc.272.37.23165. J Biol Chem. 1997. PMID: 9287320 Free article.

6

Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain.

Bakos E, Evers R, Szakács G, Tusnády GE, Welker E, Szabó K, de Haas M, van Deemter L, Borst P, Váradi A, Sarkadi B. Bakos E, et al. J Biol Chem. 1998 Nov 27;273(48):32167-75. doi: 10.1074/jbc.273.48.32167. J Biol Chem. 1998. PMID: 9822694 Free article.

7

Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions.

Bakos E, Evers R, Sinkó E, Váradi A, Borst P, Sarkadi B. Bakos E, et al. Mol Pharmacol. 2000 Apr;57(4):760-8. doi: 10.1124/mol.57.4.760. Mol Pharmacol. 2000. PMID: 10727523

8

Transition-state formation in ATPase-negative mutants of human MDR1 protein.

Szakács G, Ozvegy C, Bakos E, Sarkadi B, Váradi A. Szakács G, et al. Among authors: bakos e. Biochem Biophys Res Commun. 2000 Oct 5;276(3):1314-9. doi: 10.1006/bbrc.2000.3576. Biochem Biophys Res Commun. 2000. PMID: 11027628

9

Characterization of the amino-terminal regions in the human multidrug resistance protein (MRP1).

Bakos E, Evers R, Calenda G, Tusnády GE, Szakács G, Váradi A, Sarkadi B. Bakos E, et al. J Cell Sci. 2000 Dec;113 Pt 24:4451-61. doi: 10.1242/jcs.113.24.4451. J Cell Sci. 2000. PMID: 11082039

10

Role of glycine-534 and glycine-1179 of human multidrug resistance protein (MDR1) in drug-mediated control of ATP hydrolysis.

Szakács G, Ozvegy C, Bakos E, Sarkadi B, Váradi A. Szakács G, et al. Among authors: bakos e. Biochem J. 2001 May 15;356(Pt 1):71-5. doi: 10.1042/0264-6021:3560071. Biochem J. 2001. PMID: 11336637 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters